Image: NEC Corporation of America [CC BY 2.0], via Flickr
Medicines and Healthcare Products Regulatory Agency has raised fees by at least 10 per cent
The Medicines and Healthcare Products Regulatory Agency has raised its existing fees and introduced new ones.
From 1 April, the UK’s medicines regulator increased all its fees by at least 10 per cent, with a further uplift for 58 fees for services which it said are “significantly” under-recovering costs.
This article is only available to Research Professional News subscribers. If you are a subscriber you can read the article in full on researchprofessional.com
Pivot-RP users can log in and view the article via this link.